| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 164.856 | 144.830 | 139.362 | 144.724 | 370.555 | 60.927 | 120.373 | 103.579 | 79.637 | 2.412 |
| Total Income - EUR | 165.308 | 144.831 | 139.364 | 145.001 | 372.735 | 77.242 | 120.391 | 103.596 | 79.940 | 2.412 |
| Total Expenses - EUR | 163.249 | 143.215 | 138.528 | 144.601 | 281.968 | 87.811 | 119.303 | 103.340 | 79.553 | 2.361 |
| Gross Profit/Loss - EUR | 2.059 | 1.616 | 836 | 400 | 90.768 | -10.570 | 1.089 | 256 | 387 | 51 |
| Net Profit/Loss - EUR | 1.173 | 1.301 | 702 | 336 | 84.431 | -10.570 | 914 | 215 | 325 | 43 |
| Employees | 33 | 33 | 31 | 25 | 23 | 23 | 18 | 17 | 11 | 1 |
Check the financial reports for the company - Valdor Medical Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 134 | 26 | 0 | 0 | 0 | 310 | 260 | 217 | 172 | 128 |
| Current Assets | 637.801 | 74.553 | 173.730 | 134.581 | 123.082 | 90.588 | 31.577 | 35.570 | 25.261 | 23.439 |
| Inventories | 0 | 0 | 205 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 31.155 | 58.716 | 137.389 | 96.239 | 120.308 | 55.732 | 17.347 | 22.860 | 22.812 | 23.019 |
| Cash | 606.645 | 15.837 | 36.136 | 38.342 | 2.773 | 34.856 | 14.230 | 12.710 | 2.450 | 420 |
| Shareholders Funds | 30.096 | 31.090 | 31.266 | 31.028 | 97.126 | 2.210 | 3.075 | 3.300 | 3.615 | 3.638 |
| Social Capital | 11.294 | 11.178 | 10.989 | 10.788 | 10.579 | 10.378 | 10.148 | 10.179 | 10.149 | 10.092 |
| Debts | 607.839 | 43.489 | 142.465 | 103.553 | 25.956 | 88.688 | 28.761 | 32.486 | 21.819 | 19.929 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8210 - 8210" | |||||||||
| CAEN Financial Year |
8610
|
|||||||||
Comments - Valdor Medical Srl